SCHEMBL6042969

SCHEMBL6042969

[NH]Cc1cccc(Br)c1Br

nearest known ligand 0.42

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.42
GABRB2 P47870 1/20 0.42
IDO1 P14902 2/20 0.40
TAAR1 Q96RJ0 3/20 0.38
LMNA P02545 1/20 0.32
BLM P54132 1/20 0.32
TSHR P16473 1/20 0.31
CYP2A13 Q16696 1/20 0.31
KMT2A Q03164 1/20 0.30
CYP1A1 P04798 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP1B1 Q16678 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9016954 0.81 GABRA1 (0.48) GABRA1GABRB2IDO1TAAR1LMNA
SCHEMBL622471 0.79
SCHEMBL29562705 0.77 GABRA1 (0.44) GABRA1GABRB2IDO1TAAR1LMNA
SCHEMBL305224 0.77 GABRA1 (0.44) GABRA1GABRB2IDO1TAAR1LMNA
SCHEMBL28958233 0.75 TAAR1 (0.48) GABRA1GABRB2IDO1TAAR1
SCHEMBL4449960 0.75 GABRA1 (0.48) GABRA1GABRB2IDO1TAAR1TSHR
SCHEMBL608328 0.75 GABRA1 (0.42) GABRA1GABRB2IDO1TAAR1LMNA
SCHEMBL4896383 0.75 GABRA1 (0.42) GABRA1GABRB2IDO1TAAR1LMNA
SCHEMBL11104057 0.75 GABRA1 (0.48) GABRA1GABRB2IDO1TAAR1LMNA
SCHEMBL31192635 0.75 GABRA1 (0.42) GABRA1GABRB2IDO1TAAR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084135-A1 Compositions for manipulating the lifespan and stress response of cells and organisms BIOMOL INTERNATIONAL, INC. 2006-04-20 US disclosed
US-4728646-A ANTITHROMBOTICS DR. KARL THOMAE GMBH (DE) 1988-03-01 US disclosed
US-4690923-A ANTITHROMBOTICS KARL THOMAE GMBH (DE) 1987-09-01 US disclosed
US-4518596-A Antithrombotic use of 2-(perhydro-1,4-diazino)-pyrimido (5,4,D)-pyrimidines DR. KARL THOMAE GMBH (DE) 1985-05-21 US disclosed